AAAAAA

   
Results: 1-2 |
Results: 2
NEOADJUVANT TREATMENT BEFORE RADICAL PROSTATECTOMY DECREASES THE NUMBER OF POSITIVE MARGINS IN CT2-T3 BUT HAS NO IMPACT ON PSA PROGRESSION OR SURVIVAL, IN CT2-T3
Authors: BAERT LV GOETHUYS HJ DERIDDER DJ WERBROUCK P ACKAERT K DECOSTER MI VANPOPPEL HP
Citation: Lv. Baert et al., NEOADJUVANT TREATMENT BEFORE RADICAL PROSTATECTOMY DECREASES THE NUMBER OF POSITIVE MARGINS IN CT2-T3 BUT HAS NO IMPACT ON PSA PROGRESSION OR SURVIVAL, IN CT2-T3, The Journal of urology, 159(5), 1998, pp. 229-229
NEOADJUVANT HORMONAL-THERAPY BEFORE RADICAL PROSTATECTOMY DECREASES THE NUMBER OF POSITIVE SURGICAL MARGINS IN STAGE T2 PROSTATE-CANCER - INTERIM RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL
Authors: VANPOPPEL H DERIDDER D ELGAMAL AA VANDEVOORDE W WERBROUCK P ACKAERT K OYEN R PITTOMVILS G BAERT L ASSENMACHER C BILLIET I HARDEMAN M MATTELAER J BOECKX G CASSELMAN J DEBRUYNE R DHOEDT M DELAERE K LEONARD A MORTELMANS B VALCKE A RENDERS G VANHOUCKE JL VANOYEN P
Citation: H. Vanpoppel et al., NEOADJUVANT HORMONAL-THERAPY BEFORE RADICAL PROSTATECTOMY DECREASES THE NUMBER OF POSITIVE SURGICAL MARGINS IN STAGE T2 PROSTATE-CANCER - INTERIM RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL, The Journal of urology, 154(2), 1995, pp. 429-434
Risultati: 1-2 |